Latest Equity Raises News

First Au Limited has consolidated its flagship Victorian Goldfields Project with 100% ownership and is aggressively advancing its Nimba Gold Project in Liberia, supported by a $1.5 million capital raise and new drilling programs.

Enlitic reports a 48% revenue surge in Q2 FY25, secures a major $50 million partnership with GE HealthCare, and completes a $10 million equity raise, positioning itself for operational break-even by year-end.

Waratah Minerals has reported significant extensions of high-grade gold mineralisation at its Spur Gold-Copper Project, alongside promising porphyry copper-gold intersections at Breccia West. The company also secured $8.4 million in new equity to accelerate drilling activities.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.

Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.

Syrah Resources has launched a fully underwritten A$70 million equity raising to support its Balama graphite operations and Vidalia Active Anode Material facility, alongside securing a two-year forbearance on its US Department of Energy loan. The company advances commercial qualification of Vidalia AAM amid strong demand and US tariff support.

Syrah Resources has launched a A$70 million equity raising and secured a two-year forbearance on its US Department of Energy loan, bolstering its cash position and operational flexibility amid ongoing challenges.

Transurban Group reveals modest participation in its latest Distribution Reinvestment Plan, with new securities priced at $13.4692 ahead of the August payment date.

Arizona Lithium has secured regulatory approval for Phase 1 production at its Prairie Lithium Project in Saskatchewan and raised $4.25 million through an oversubscribed share purchase plan, marking key milestones toward commercial lithium extraction.

Legacy Minerals reports a robust Stage 1 Scoping Study for its Drake Project, confirming strong economics and production potential, while inaugural drilling at the Thomson Project and a $7.75 million capital raise set the stage for accelerated exploration.

Terra Metals has raised $4 million from strategic investors to fund further exploration at its Dante Project, where recent drilling confirms high-grade mineralisation and supports a forthcoming maiden resource estimate.

Neurizon Therapeutics has secured a $1.5 million loan against its expected 2025 R&D tax rebate, boosting liquidity without diluting shareholders. This strategic move supports ongoing development of its neurodegenerative disease treatments.